{
  "nct_id": "NCT88876707",
  "indication": "Major Depressive Disorder",
  "phase": "Phase 3",
  "sample_size": 946,
  "duration_weeks": 33,
  "dropout_rate": 0.24,
  "blinding": "open-label",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "MADRS score reduction"
  ],
  "secondary_endpoints": [
    "Response rate",
    "HAM-D score reduction"
  ],
  "outcome_summary": "Failed to reach statistical significance on primary endpoint",
  "success": 0,
  "failure_reason": "Pharmacokinetic issues with drug exposure",
  "start_date": "2021-10-08",
  "completion_date": "2022-05-27"
}